Pacific Biosciences of California, Inc. (PACB) vs VAREX IMAGING (VREX)
- Pacific Biosciences of California, Inc. PACB 1.73 −11.73%
- VAREX IMAGING VREX 18.41 −0.32%
Pacific Biosciences of California, Inc. and VAREX IMAGING are both Medical Devices companies. VAREX IMAGING is the larger, with a market value of $784.3M against $609.2M — 1.3× the size. Pacific Biosciences of California, Inc. has negative trailing earnings, so its P/E is not meaningful; VAREX IMAGING trades at 34.7×. VAREX IMAGING grew revenue faster over the last twelve months: 5.31% against 2.02%. VAREX IMAGING has the higher net margin (2.55% vs −82.5%) and the higher return on invested capital (5.95% vs −22.2%). Across the 17 metrics below, VAREX IMAGING leads on 12 and Pacific Biosciences of California, Inc. on 5.
Valuation
Profitability
| Metric | PACB | VREX | Medical Devices median |
|---|---|---|---|
| Gross margin | 36.38% | 34.32% | 56.01% |
| Operating margin | (83.53%) | 8.35% | (15.03%) |
| Net margin | (82.49%) | 2.55% | (20.40%) |
| Free cash flow margin | (50.53%) | (2.34%) | (7.24%) |
| Return on equity | (929.31%) | 4.51% | (15.32%) |
| Return on assets | (16.66%) | 2.03% | (19.72%) |
| Return on invested capital | (22.22%) | 5.95% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack